These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 24754171)
21. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles. Fini A; Cavallari C; Ospitali F Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516 [TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier. Yin LF; Huang SJ; Zhu CL; Zhang SH; Zhang Q; Chen XJ; Liu QW Drug Dev Ind Pharm; 2012 Nov; 38(11):1371-80. PubMed ID: 22296267 [TBL] [Abstract][Full Text] [Related]
23. The effect of drug and EUDRAGIT® S 100 miscibility in solid dispersions on the drug and polymer dissolution rate. Higashi K; Hayashi H; Yamamoto K; Moribe K Int J Pharm; 2015 Oct; 494(1):9-16. PubMed ID: 26253374 [TBL] [Abstract][Full Text] [Related]
24. Eudragit® S100 coated calcium pectinate microspheres of curcumin for colon targeting. Zhang L; Cao F; Ding B; Li Q; Xi Y; Zhai G J Microencapsul; 2011; 28(7):659-67. PubMed ID: 21824069 [TBL] [Abstract][Full Text] [Related]
25. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets. Akhgari A; Sadeghi F; Garekani HA Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290 [TBL] [Abstract][Full Text] [Related]
26. Solid dispersion of spironolactone with porous silica prepared by the solvent method. Uchino T; Yasuno N; Yanagihara Y; Suzuki H Pharmazie; 2007 Aug; 62(8):599-603. PubMed ID: 17867555 [TBL] [Abstract][Full Text] [Related]
27. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres. Rawat M; Saraf S; Saraf S AAPS PharmSciTech; 2007 Dec; 8(4):E116. PubMed ID: 18181537 [TBL] [Abstract][Full Text] [Related]
28. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique. Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408 [TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of coenzyme Q10-Eudragit solid dispersion. Nazzal S; Guven N; Reddy IK; Khan MA Drug Dev Ind Pharm; 2002 Jan; 28(1):49-57. PubMed ID: 11858524 [TBL] [Abstract][Full Text] [Related]
30. [Effects of micronization on micromeritics properties of baicalin]. Yan HM; Ding DM; Sun E; Wang J; Jia XB; Zhang ZH Zhongguo Zhong Yao Za Zhi; 2014 Feb; 39(4):653-6. PubMed ID: 25204141 [TBL] [Abstract][Full Text] [Related]
31. [Study on dispersivity of baicalin solid dispersion by vibrational spectrometry]. Wang W; Li X; Tian J; Xi X; Cheng L Zhongguo Zhong Yao Za Zhi; 2011 Mar; 36(5):573-5. PubMed ID: 21657074 [TBL] [Abstract][Full Text] [Related]
32. Citric acid as a solid-state plasticizer for Eudragit RS PO. Schilling SU; Shah NH; Malick AW; Infeld MH; McGinity JW J Pharm Pharmacol; 2007 Nov; 59(11):1493-500. PubMed ID: 17976259 [TBL] [Abstract][Full Text] [Related]
33. An investigation into the dissolution properties of celecoxib melt extrudates: understanding the role of polymer type and concentration in stabilizing supersaturated drug concentrations. Abu-Diak OA; Jones DS; Andrews GP Mol Pharm; 2011 Aug; 8(4):1362-71. PubMed ID: 21696180 [TBL] [Abstract][Full Text] [Related]
34. Physicochemical characterization of solid dispersions of three antiepileptic drugs prepared by solvent evaporation method. Douroumis D; Bouropoulos N; Fahr A J Pharm Pharmacol; 2007 May; 59(5):645-53. PubMed ID: 17524229 [TBL] [Abstract][Full Text] [Related]
35. To evaluate the effect of addition of an anionic surfactant on solid dispersion using model drug indomethacin. Dave RH; Patel AD; Donahue E; Patel HH Drug Dev Ind Pharm; 2012 Aug; 38(8):930-9. PubMed ID: 22085470 [TBL] [Abstract][Full Text] [Related]
36. Mebeverine-loaded electrospun nanofibers: physicochemical characterization and dissolution studies. Illangakoon UE; Nazir T; Williams GR; Chatterton NP J Pharm Sci; 2014 Jan; 103(1):283-92. PubMed ID: 24258335 [TBL] [Abstract][Full Text] [Related]
37. Curcumin-Eudragit® E PO solid dispersion: A simple and potent method to solve the problems of curcumin. Li J; Lee IW; Shin GH; Chen X; Park HJ Eur J Pharm Biopharm; 2015 Aug; 94():322-32. PubMed ID: 26073546 [TBL] [Abstract][Full Text] [Related]
38. Eudragit FS based colonic microparticls of metoprolol tartrate. Rasool F; Ahmad M; Murtaza G; Khan HM; Khan SA Acta Pol Pharm; 2012; 69(2):347-53. PubMed ID: 22568051 [TBL] [Abstract][Full Text] [Related]
39. Enhancement of dissolution profile by solid dispersion (kneading) technique. Modi A; Tayade P AAPS PharmSciTech; 2006 Aug; 7(3):68. PubMed ID: 17025249 [TBL] [Abstract][Full Text] [Related]
40. Development of pH- and enzyme-controlled, colon-targeted, pulsed delivery system of a poorly water-soluble drug: preparation and in vitro evaluation. Lai H; Lin K; Zhang W; Zhang Z; Jie L; Wu Y; He Q Drug Dev Ind Pharm; 2010 Jan; 36(1):81-92. PubMed ID: 19640246 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]